NxStage Medical (NXTM) Posts Q2 Loss of $0.17, Narrower than Views; Increases FY10 Rev Outlook, Guides Q3
Tweet Send to a Friend
NxStage Medical, Inc. (Nasdaq: NXTM) reports Q2 loss of $0.17, 1 cent better than the analyst estimate of ($0.18) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
